DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis
DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading provider of ...
StudyFinds on MSN6h
Breakthrough blood test could transform ALS diagnosis, care
Find out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.
Four immunoassays for neurofilament light chain show consistent performance in amyotrophic lateral sclerosis
Four immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophic lateral ...
Science Daily5d
Blood test could lead to better diagnosis and management of ALS
ALS, or amyotrophic lateral sclerosis, can sometimes be difficult to diagnose or to predict how quickly the disease is likely to progress. A new study helps determine which blood tests are best at ...
Blood test can help diagnose, track ALS patients, French study indicates
A blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and predict how the degenerative disease will ...
News Medical on MSN9h
Stress granules as potential biomarkers for neurodegenerative diseases
Stress granules (SGs) are transient organelles that form when cells experience stress, serving as critical hubs for RNA metabolism and cellular survival.
DiagnaMed Holdings Corp.: DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis
DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading provider of cutting-edge technology solutions ...
emjreviews.com1d
Tetramethylpyrazine Nitrone Benefits Grip Strength in Younger Patients with ALS
Tetramethylpyrazine nitrone is safe for ALS and may slow grip strength decline, especially in younger patients.
HealthDay on MSN4d
Four Immunoassays for Neurofilament Light Chain Show Consistent Performance in ALS
Four immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophi ...
Athira Pharma Reports Full Year 2024 Financial Results and Pipeline and Business Updates
Completed healthy volunteer Phase 1 clinical study of ATH-1105 as a potential treatment for amyotrophic lateral sclerosis (ALS)On-track to enable ...
Medpage Today on MSN4d
Novel Agent Safe in ALS, Phase II Study Suggests
Tetramethylpyrazine nitrone was safe for people with amyotrophic lateral sclerosis (ALS), but neither a high nor low daily ...